Neuroinflammation Research: Mitoquinoluinol (Mitoquinol), Exercise, and Gene Expression in Multiple Sclerosis
Written by Tyla Cornish (BNatMed), Naturopath. Reviewed by Dr. Siobhan Mitchell (PhD), Neuroscience.
Multiple sclerosis (MS) is characterised by chronic inflammation and neurodegeneration, with oxidative stress playing a key role in disease progression. Mitochondrial dysfunction is increasingly recognised as a contributor to this inflammatory environment, making mitochondria-targeted approaches a logical area of investigation. This study examined whether mitochondrial antioxidant supplementation, alone or combined with exercise, could influence inflammatory and immune signalling pathways in women with MS.
Research Summary
Evidence type: Randomised controlled trial
Claim strength: Causal (biomarker endpoints), positive
Population: 108 women with MS (pre- and post-menopausal)
Intervention: Mitoquinol 20 mg/day; exercise training; combined Mitoquinol + exercise (period of 8 weeks)
Primary outcomes: IL-6, STAT1, SMAD2, TGF-β gene expression
Observed outcome: Reduced pro-inflammatory markers (IL-6, STAT1); increased anti-inflammatory signalling (TGF-β, SMAD2); greater effects with combined intervention
Causality: Supported for molecular endpoints
What you’ll learn
Whether mitochondrial-targeted antioxidants can influence inflammatory signalling in multiple sclerosis
How oxidative stress and immune dysregulation contribute to MS pathophysiology
The potential additive effects of combining supplementation with exercise
Why short-term molecular changes may not immediately translate into clinical outcomes
Why Inflammation and Oxidative Stress Were Targeted
MS involves chronic immune activation and elevated oxidative stress, leading to progressive neuronal damage and clinical decline. Targeting these intersecting pathways may help modulate disease activity at a molecular level, and the combination of mitochondrial support with exercise — itself an anti-inflammatory intervention — provides a rationale for examining additive effects.
What the Trial Observed
Participants were assigned to Mitoquinol, exercise, combined therapy, or a control condition for eight weeks. The study found reductions in the pro-inflammatory markers IL-6 and STAT1, alongside increases in the anti-inflammatory mediators TGF-β and SMAD2. These effects were most pronounced in the combined Mitoquinol and exercise group, suggesting a degree of synergy between mitochondrial antioxidant supplementation and exercise-induced immune modulation.
What Are the Implications for MS Management?
These findings suggest that mitochondria-targeted interventions can influence key immune signalling pathways relevant to MS pathophysiology. The molecular effects observed are likely to reflect mechanistic rather than clinical benefit over an eight-week period, but they provide an important basis for longer trials designed to assess whether sustained modulation of these pathways produces clinically meaningful outcomes. The amplified response with combined intervention reinforces the value of integrating supplementation with structured physical activity.
The consistent shift in both pro- and anti-inflammatory signalling pathways indicates that mitochondrial support may help rebalance immune regulation in MS, particularly in individuals with elevated inflammatory burden. In clinical practice, this points toward potential utility in supporting systemic inflammatory tone alongside established therapies, especially where fatigue, reduced exercise tolerance, or metabolic dysfunction are present. However, given the short duration and biomarker-focused outcomes, these interventions are best viewed as adjunctive and hypothesis-generating, reinforcing the importance of longer-term trials that assess symptom progression, relapse rates, and functional outcomes.
What Should Practitioners Know About Dosing and Use?
Participants took 20 mg daily for eight weeks. The intervention was well tolerated and produced meaningful modulation of inflammatory and regulatory gene expression, with the strongest effects observed when supplementation was combined with exercise — a consideration relevant to the design of future clinical programmes in this population.
Read the full paper:Effect of exercise, Mitoquinol, and their combination on inflammatory and gene expression in women with multiple sclerosis
DOI: 10.18502/ijaai.v23i6.17377
